Dayal D, Verma Attri S, Kumar Bhalla A, Kumar R. Response to low dose indomethacin in two children with nephrogenic diabetes insipidus. Pediatric Endocrinology Diabetes and Metabolism. 2014;20(4).
APA
Dayal, D., Verma Attri, S., Kumar Bhalla, A., & Kumar, R. (2014). Response to low dose indomethacin in two children with nephrogenic diabetes insipidus. Pediatric Endocrinology Diabetes and Metabolism, 20(4).
Chicago
Dayal, Devi, Savita Verma Attri, Anil Kumar Bhalla, and Rakesh Kumar. 2014. "Response to low dose indomethacin in two children with nephrogenic diabetes insipidus". Pediatric Endocrinology Diabetes and Metabolism 20 (4).
Harvard
Dayal, D., Verma Attri, S., Kumar Bhalla, A., and Kumar, R. (2014). Response to low dose indomethacin in two children with nephrogenic diabetes insipidus. Pediatric Endocrinology Diabetes and Metabolism, 20(4).
MLA
Dayal, Devi et al. "Response to low dose indomethacin in two children with nephrogenic diabetes insipidus." Pediatric Endocrinology Diabetes and Metabolism, vol. 20, no. 4, 2014.
Vancouver
Dayal D, Verma Attri S, Kumar Bhalla A, Kumar R. Response to low dose indomethacin in two children with nephrogenic diabetes insipidus. Pediatric Endocrinology Diabetes and Metabolism. 2014;20(4).
Two children with nephrogenic diabetes insipidus (NDI) were treated with oral indomethacin (0.75-1.2 mg/kg/day) three times a day for a mean duration of 3 yrs. Remission occurred in both patients in terms of achieving a normal fluid balance and body growth and the drug was withdrawn in one patient after 2 yrs. The treatment was well tolerated and no side effects were noted. The mean duration of follow-up was 6.5 yrs. These long-term observations of a favourable response to low dose indomethacin in 2 children with NDI need to be tested on larger number of patients.
Keywords
nephrogenic diabetes insipidus, cyclooxygenase inhibitors, indomethacin, children